首页 >
法规速递
-
国家药监局综合司关于印发化妆品企业生产质量管理体系提升三年行动计划（2026—2028年）的通知 -2025/12/12
2025-12-15查看详情 > -
国家药监局药审中心关于发布《多糖结合疫苗核磁共振研究的技术考虑（试行）》的通告（2026年第8号）-2026/1/26
2026-01-27查看详情 > -
国家药监局药审中心关于发布《慢性鼻窦炎伴鼻息肉治疗药物临床试验技术指导原则》的通告（2026年第17号）-2026/3/4
2026-03-05查看详情 > -
Page: Clinical investigation of medicinal products for the treatment of amyotrophic lateral sclerosis - Scientific guideline-2026/3/31
2026-04-01查看详情 > -
Document: Timetable: Initial (full) marketing authorisation application accelerated assessment timetables - Advanced therapy medicinal product (ATMP)-2026/5/13
2026-05-14查看详情 > -
Document: Step-by-step guide : Support with workload management in the authority workspace - CTIS Training Programme - Module 04-2026/6/26
2026-06-29查看详情 > -
Regulatory and procedural guideline: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure-2022/11/4
2022-11-30查看详情 > -
Final Guidance: Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products-2023/5/25
2023-05-30查看详情 > -
关于公开征求《罕见疾病药物临床研发中应用去中心化临床试验的技术指导原则》意见的通知-2023/11/24
2023-11-28查看详情 > -
Document: Agenda: SPOR & XEVMPD status update webinar - 22 January 2025-2025/1/20
2025-01-21查看详情 >
